BOIRON : ACTIVITY IN THE THIRD QUARTER OF 2013

le
0

ACTIVITY IN THE THIRD QUARTER OF 2013
(Unaudited data)

  • CUMULATIVE ACTIVITY AS OF THE END OF SEPTEMBER 2013
thousands of euros 2012 2013 Variation at current exchange rates Variation at constant exchange rates
France 233,426 252,193 + 8.0% + 8.0%
International : 165,959 193,077 + 16.3% + 18.4%
Incl. Europe excluding France 126,041 144,637 + 14.8% + 16.3%
Incl. North America 31,282 37,732 + 20.6% + 24.4%
Incl. Other countries 8,636 10,708 + 24.0% + 27.4%
Group Total 399,385 445,270 + 11.5% + 12.3%

thousands of euros 2012 2013 Variation at current exchange rates Variation at constant exchange rates
Non-proprietary Homeopathic Medicines 213,592 225,694 + 5.7% + 5.9%
OTC Specialties 185,394 219,279 + 18.3% + 19.9%
Other 399 297 - 25.6% - 29.1%
Group Total 399,385 445,270 + 11.5% + 12.3%
  • DEVELOPMENT OF BUSINESS IN THE THIRD QUARTER (VARIATION AT CURRENT RATE)
thousands of euros 1st Quarter 2nd Quarter 3rd Quarter
2012 2013 Var.
13/12
2012 2013 Var.
13/12
2012 2013 Var.
13/12
France 74,188 84,270 + 13.6% 71,210 75,327 + 5.8% 88,028 92,596 + 5.2%
International : 54,904 73,751 + 34.3% 41,216 42,436 + 3.0% 69,839 76,890 + 10.1%
Incl. Europe excluding France 41,807 54,334 + 30.0% 28,889 29,047 + 0.5% 55,345 61,256 + 10.7%
Incl. North America 10,285 15,562 + 51.3% 9,861 10,017 + 1.6% 11,136 12,153 + 9.1%
Incl. Other countries 2,812 3,855 + 37.1% 2,466 3,372 + 36.7% 3,358 3,481 + 3.7%
Group Total 129,092 158,021 + 22.4% 112,426 117,763 + 4.7% 157,867 169,486 + 7.4%

thousands of euros 1st Quarter 2nd Quarter 3rd Quarter
2012 2013 Var.
13/12
2012 2013 Var.
13/12
2012 2013 Var.
13/12
Non-proprietary Homeopathic Medicines 73,427 79,062 + 7.7% 70,206 73,035 + 4.0% 69,959 73,597 + 5.2%
OTC Specialties 55,576 78,866 + 41.9% 42,007 44,600 + 6.2% 87,811 95,813 + 9.1%
Other 89 93 + 4.5% 213 128 - 39.9% 97 76 - 21.6%
Group Total 129,092 158,021 + 22.4% 112,426 117,763 + 4.7% 157,867 169,486 + 7.4%
  • HIGHLIGHTS OF THE THIRD QUARTER

Sales revenue in the third quarter 2013 grew by 7.4% compared to 2012 (8.9% at constant rates).

The increase is due to the sales:

  • of Non-proprietary Homeopathic Medicines, in particular in France, Italy and the USA.
  • of winter Specialties, in particular in France, Italy and Russia.

On September 30, 2013, the group cash balance amounted ¤116.4 million versus ¤94.7 million on December 31, 2012.

  • OUTLOOK

Considering this performance, Boiron confirms its target of further increases of its business and profitability in 2013.

Our next update: January 23, 2014 at market close, publication of the sales revenue for the year 2013.
Financial information manager: Philippe MONTANT
Contact for financial information: Véronique BOUSCAYROL
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PA
The group's financial information is online at : www.boiron.com

Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-33859-cp_boiron-241013.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant